These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31511648)

  • 41. Contributions of the Epstein-Barr virus EBNA1 protein to gastric carcinoma.
    Sivachandran N; Dawson CW; Young LS; Liu FF; Middeldorp J; Frappier L
    J Virol; 2012 Jan; 86(1):60-8. PubMed ID: 22013060
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells.
    Westhoff Smith D; Chakravorty A; Hayes M; Hammerschmidt W; Sugden B
    mBio; 2021 Dec; 12(6):e0224321. PubMed ID: 34781735
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B; Sample CE
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Epstein-Barr Virus Facilitates Expression of KLF14 by Regulating the Cooperative Binding of the E2F-Rb-HDAC Complex in Latent Infection.
    Pei Y; Wong JH; Jha HC; Tian T; Wei Z; Robertson ES
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32847849
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Epstein-Barr viral nuclear antigen 1 antisense oligodeoxynucleotide inhibits proliferation of Epstein-Barr virus-immortalized B cells.
    Roth G; Curiel T; Lacy J
    Blood; 1994 Jul; 84(2):582-7. PubMed ID: 8025284
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An EBNA3A-Mutated Epstein-Barr Virus Retains the Capacity for Lymphomagenesis in a Cord Blood-Humanized Mouse Model.
    Romero-Masters JC; Ohashi M; Djavadian R; Eichelberg MR; Hayes M; Zumwalde NA; Bristol JA; Nelson SE; Ma S; Ranheim EA; Gumperz JE; Johannsen EC; Kenney SC
    J Virol; 2020 May; 94(10):. PubMed ID: 32132242
    [TBL] [Abstract][Full Text] [Related]  

  • 47. EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspases.
    Jha HC; Lu J; Saha A; Cai Q; Banerjee S; Prasad MA; Robertson ES
    J Virol; 2013 Nov; 87(22):12121-38. PubMed ID: 23986604
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains.
    Tierney RJ; Kao KY; Nagra JK; Rickinson AB
    J Virol; 2011 Dec; 85(23):12362-75. PubMed ID: 21957300
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Epstein-Barr virus latent membrane protein (LMP1) and nuclear proteins 2 and 3C are effectors of phenotypic changes in B lymphocytes: EBNA-2 and LMP1 cooperatively induce CD23.
    Wang F; Gregory C; Sample C; Rowe M; Liebowitz D; Murray R; Rickinson A; Kieff E
    J Virol; 1990 May; 64(5):2309-18. PubMed ID: 2157887
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.
    Daskalogianni C; Pyndiah S; Apcher S; Mazars A; Manoury B; Ammari N; Nylander K; Voisset C; Blondel M; Fåhraeus R
    J Pathol; 2015 Jan; 235(2):334-41. PubMed ID: 25186125
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Epstein-Barr Virus B Cell Growth Transformation: The Nuclear Events.
    Zhao B
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112815
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Targeting Epstein-Barr virus oncoprotein LMP1-mediated high oxidative stress suppresses EBV lytic reactivation and sensitizes tumors to radiation therapy.
    Hu J; Li Y; Li H; Shi F; Xie L; Zhao L; Tang M; Luo X; Jia W; Fan J; Zhou J; Gao Q; Qiu S; Wu W; Zhang X; Liao W; Bode AM; Cao Y
    Theranostics; 2020; 10(26):11921-11937. PubMed ID: 33204320
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Transcription of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene occurs before induction of the BCR2 (Cp) EBNA gene promoter during the initial stages of infection in B cells.
    Schlager S; Speck SH; Woisetschläger M
    J Virol; 1996 Jun; 70(6):3561-70. PubMed ID: 8648690
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Metabolic stress is a barrier to Epstein-Barr virus-mediated B-cell immortalization.
    McFadden K; Hafez AY; Kishton R; Messinger JE; Nikitin PA; Rathmell JC; Luftig MA
    Proc Natl Acad Sci U S A; 2016 Feb; 113(6):E782-90. PubMed ID: 26802124
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epstein-Barr virus nuclear antigen 2 inhibits AID expression during EBV-driven B-cell growth.
    Tobollik S; Meyer L; Buettner M; Klemmer S; Kempkes B; Kremmer E; Niedobitek G; Jungnickel B
    Blood; 2006 Dec; 108(12):3859-64. PubMed ID: 16882707
    [TBL] [Abstract][Full Text] [Related]  

  • 56. CD19 signalling improves the Epstein-Barr virus-induced immortalization of human B cell.
    Hur DY; Lee MH; Kim JW; Kim JH; Shin YK; Rho JK; Kwack KB; Lee WJ; Han BG
    Cell Prolif; 2005 Feb; 38(1):35-45. PubMed ID: 15679865
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Comparison of EBV-infectivity measured by EBNA-induction and immortalization of human B-cells.
    Cho MS; Louie RE
    Biologicals; 1992 Mar; 20(1):45-50. PubMed ID: 1319181
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Notch1, Notch2, and Epstein-Barr virus-encoded nuclear antigen 2 signaling differentially affects proliferation and survival of Epstein-Barr virus-infected B cells.
    Kohlhof H; Hampel F; Hoffmann R; Burtscher H; Weidle UH; Hölzel M; Eick D; Zimber-Strobl U; Strobl LJ
    Blood; 2009 May; 113(22):5506-15. PubMed ID: 19339697
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Epstein-barr virus infection of monocytoid B-cell proliferates: an early feature of primary viral infection?
    Anagnostopoulos I; Hummel M; Falini B; Joehrens K; Stein H
    Am J Surg Pathol; 2005 May; 29(5):595-601. PubMed ID: 15832082
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential anti-tumour effects of MTH1 inhibitors in patient-derived 3D colorectal cancer cultures.
    van der Waals LM; Laoukili J; Jongen JMJ; Raats DA; Borel Rinkes IHM; Kranenburg O
    Sci Rep; 2019 Jan; 9(1):819. PubMed ID: 30692572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.